Semax 30mg — Research Overview

Semax (MEHFPGP) is a synthetic heptapeptide analogue of the ACTH(4-10) fragment developed to retain specific peptide-signaling properties while exhibiting a distinct pharmacological profile. Experimental investigations have examined its interactions with melanocortin-associated signaling pathways, peptide-mediated regulatory networks, transcriptional control mechanisms, and signal transduction processes. Studies have also explored its influence on molecular signaling systems, receptor-associated regulatory pathways, and peptide-dependent cellular communication mechanisms. Research applications include neuropeptide pharmacology, melanocortin pathway investigation, peptide-signaling research, transcriptional regulation studies, receptor-ligand interaction analysis, and mechanistic evaluation of peptide-mediated signaling systems.

• High Purity – 99% Purity Guaranteed
• Independently Lab Tested
• Research Grade Quality
• For Laboratory Research Use Only

Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.

Semax 30mg Chemical Properties

Semax 30mg Research Applications

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of the ACTH(4-10) fragment. The ACTH(4-10) region lacks the steroidogenic activity associated with the N-terminal ACTH sequence while retaining interactions with melanocortin-associated signaling systems. Experimental investigations have examined Semax in relation to transcriptional regulation processes, melanocortin pathway activity, ERK/MAPK-associated signaling networks, and peptide-mediated regulatory mechanisms. Studies have also explored its influence on receptor-associated signaling systems, molecular communication pathways, and downstream regulatory processes involved in peptide pharmacology. Its heptapeptide sequence includes a C-terminal Pro-Gly-Pro motif that influences peptide stability characteristics and resistance to enzymatic degradation relative to shorter ACTH-derived fragments. These properties have established Semax as a valuable research tool for neuropeptide pharmacology, melanocortin pathway investigation, signal transduction research, receptor-ligand interaction studies, transcriptional regulation analysis, and mechanistic evaluation of peptide-mediated signaling systems. Supplied as a lyophilized preparation (30 mg/vial). Independently third-party HPLC-tested; COA available per batch.

Semax 30mg Frequently Asked Questions

Research Use Disclaimer

All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.